Skip to main content
. 2014 Jan 20;9(1):e84072. doi: 10.1371/journal.pone.0084072

Figure 6. Immunocytochemical analyses of spheres derived from the EGFP+ cells of craniofacial and trunk regions.

Figure 6

(A) Expression of pluripotency markers (Nanog, Oct3/4, PAR4 and Sox2), except SSEA3, in EGFP+ spheres derived from both regions. (B) Differential expression of NCC markers (Ap2α, Ap2β, PDGFRα, PDGFRβ and Sox10) in spheres between craniofacial and trunk EGFP+ cells (scale bar; 20 µm).